These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3801264)

  • 1. Carcinoma of prostate: the effect of oestrogens on blood viscosity.
    Nandi SR; Knox J
    Br J Clin Pract; 1986 Sep; 40(9):383-5. PubMed ID: 3801264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolactin and cancer of the prostate (III). Changes in plasma prolactin and testosterone after hormone treatment in prostatic cancer].
    Maganto Pavón E; Mateos Torres JA; Mayayo Dehesa T; Allona Almagro A; Boronat Tormo F; Escudero Barrilero A
    Arch Esp Urol; 1982; 35(4):222-33. PubMed ID: 7138091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of serum ceruloplasmin levels in prostate diseases: preliminary investigation of the effect of therapeutic estrogens on serum levels of this protein].
    Bélanger L
    Union Med Can; 1971 Aug; 100(8):1554-62. PubMed ID: 5561247
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
    Daponte DP; Stevens I; Robinson MR
    Actas Urol Esp; 1986; 10(6):437-40. PubMed ID: 3825644
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breast cancer induced by estrogens in a prostate cancer patient].
    Suhler A; Naman H; Masselot R; Varini JP; Claudel P
    J Urol (Paris); 1983; 89(5):355-9. PubMed ID: 6631043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of estrogens in the regulation of membrane microviscosity.
    Tsuda K; Nishio I
    Circ Res; 2004 Feb; 94(2):e17. PubMed ID: 14764651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intra- and extracellular electrolyte concentration of estrogen therapy on patients with carcinoma of the prostate (author's transl)].
    Kunze U; Orestano F
    Urologe A; 1973 Sep; 12(5):274-7. PubMed ID: 4762689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of oestrogens on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)].
    Varenhorst E; Carlström K; Karlberg BE; Risberg B; Wallentin L; Wranne B
    Urologe A; 1982 Jan; 21(1):34-8. PubMed ID: 6805122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of megestrol acetate as monotherapy in disseminated prostatic carcinoma].
    Gallo Rolania FJ
    Arch Esp Urol; 1998 Mar; 51(2):151-3. PubMed ID: 9586312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems of the diagnosis of prostatic carcinoma during hormonal therapy].
    König K; Städtler F
    Urologe; 1970 May; 9(3):144-6. PubMed ID: 5521798
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antithrombin III levels in patients with advanced carcinoma of the prostate treated with estrogens].
    Montserrat Orri V; de Torres Mateos JA; Malet Carreras JM; Idoipe Tomás JI; Morote Robles J
    Actas Urol Esp; 1985; 9(4):327-30. PubMed ID: 4050560
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of alpha 1-antitrypsin in blood of patients operated on for tumor and benign hyperplasia of the prostate].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):77-8. PubMed ID: 8756736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer.
    Pomerantz M; Manola J; Taplin ME; Bubley G; Inman M; Lowell J; Beard C; Kantoff PW; Oh WK
    J Urol; 2007 Jun; 177(6):2146-50. PubMed ID: 17509304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The activity of alpha-2 macroglobulin in the blood of patients with prostatic carcinoma].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F; Zastawna E
    Pol Merkur Lekarski; 1997 Jan; 2(9):196-8. PubMed ID: 10907027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolysis in prostate carcinomas of varying grades of differentiation with respect to estrogen therapy and castration].
    Oehler D; Feustel A
    Z Urol Nephrol; 1980 Mar; 73(3):201-10. PubMed ID: 7434984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and therapy of prostatic carcinoma].
    Vahlensieck W; Tümmers H; Tschischak D
    Fortschr Med; 1974 Oct; 92(30):1195-8. PubMed ID: 4138473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.